Latest Competition News

Mad Paws Holdings Limited shares have been suspended from the ASX following court approval of its acquisition by Rover Group, Inc. This marks a significant milestone in the pet services sector consolidation.

Mad Paws Holdings has secured court approval for its acquisition by Rover Group, marking a key milestone with trading suspension imminent and cash payouts scheduled.

Anteris Technologies has updated the timetable for its Australian capital raising, delaying settlement to November 4 and the start of trading for new securities to November 5. The company also highlights restrictions on U.S. investors acquiring its CDIs.

The Supreme Court of New South Wales has approved Rover Group’s acquisition of Mad Paws, marking a pivotal moment for Australia’s leading pet services marketplace. The scheme will become effective this week, triggering share suspension and a new chapter for Mad Paws.

Nutritional Growth Solutions (ASX – NGS) has locked in a $2 million capital raise through a share placement aimed at fueling sales, inventory, and growth initiatives, pending shareholder approval.

Immutep Limited has received a significant A$4.6 million cash payment from the French government’s R&D tax incentive scheme, supporting its ongoing immunotherapy clinical programs.

RocketDNA has raised $4 million through a well-supported placement to accelerate production and software development, following significant contract wins with mining giants BHP Mitsubishi Alliance and Gold Fields.

West Cobar Metals has raised $1.5 million through a discounted share placement to fund key exploration and testwork at its critical minerals projects, signalling renewed momentum in its development pipeline.

Orthocell has completed its first Remplir™ surgical case in Hong Kong, marking a pivotal step in its Asian commercialisation strategy. The launch at the Hong Kong Orthopaedic Association Congress and partnership with MontsMed set the stage for broader regional growth.

Anteris Technologies has secured FDA approval to commence its pivotal PARADIGM clinical trial, testing its innovative DurAVR Transcatheter Heart Valve against established devices in patients with severe aortic stenosis.

TechGen Metals has significantly expanded its Western Australian gold footprint with three new exploration licences adjoining Ramelius Resources’ prolific Dalgaranga Gold Project, positioning itself as a key player in a proven gold corridor.

West African Resources reported robust Q3 gold production of 92,721 ounces at a competitive all-in sustaining cost, while navigating ongoing discussions with the Burkina Faso government over increased ownership in its Kiaka project.